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Abstract
PURPOSE: The purpose of this project is to evaluate the knowledge, attitudes, perceptions,
skills, and self-efficacy of dermatology providers’ assessment of depression in patients with
chronic skin disease to determine the need for continuing education programs.
METHODS: This is a single practice, multi site, quantitative correlational design study to
assess provider use, comfort, and proficiency of screening and discussion of depression in
patients suffering from plaque psoriasis and atopic dermatitis. Data was collected through the use
of a questionnaire dispensed in January of 2018. The sample consisted of 23 dermatology
providers in a dermatology practice with clinics in Louisville, Lebanon, Leitchfield, and
Shelbyville, Kentucky as well as New Albany, Indiana.
RESULTS: No statistical differences were seen in demographics, attitudes, perceived behavioral
control, confidence, and barriers between providers who screen and those who do not screen.
However, the 12 providers in the screening group and the 5 providers in the non-screening group
showed significant difference in intention (p=.02) as well as subjective norms (p=.04) scores in
the assessment of the theory of planned behavior. In addition, all 17 providers who participated
in the study indicated the lack of training in the screening for and discussion of depression in the
dermatology setting
CONCLUSION: Insight into the factors that influence the practice of screening for depression in
patients with skin disease can lead to understanding the educational needs of the dermatology
provider. In the future, additional research needs to be completed to better understand what
topics should be included in educational programs. The primary goal of this research is to
increase the number of dermatology patients who benefit from a more holistic method of care.
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Introduction
Dermatological disorders can affect a patient’s appearance, social interactions, emotions
and day-to-day life more negatively than many other chronic diseases (Safikhani, Sundaram,
Bao, Mulani, & Revicki, 2013; Chren, Lasek, Quinn, Mostow, & Zyzanski, 1996). Patients with
skin disease can have low self-esteem, impaired self-image, embarrassment, sexual dysfunction
and impaired coping practices due to obvious changes in physical appearance (Kemmerling,
2013). In addition, certain symptoms of chronic skin disease may also lead to depression and/or
decreased quality of life (QOL; Ando et al., 2006). Symptoms of skin disease can include severe
dryness, pruritus (severe itching), sensitivity and pain caused by irritated lesions (National
Institute of Arthritis and Musculoskeletal and Skin Diseases, 2015; Peters, 2016). The National
Psoriasis Foundation (NPF; 2015) estimates that 7.5 million Americans endure psoriasis while
the National Eczema Association (NEA; 2014) approximates 31.6 million Americans have
chronic dry skin, also known as atopic dermatitis and/or eczema. Collectively, these numbers
account for almost 12.5% of the American population that suffer from eczema and psoriasis
alone.
Researchers have discovered that the prevalence of depression in the general United
States population is 6-8% while the frequency of depression in patients with skin disease can
range from 21% to as high as 62% (Picardi et al, 2004; Esposito, Saraceno, Giunta, Maccarone,
& Chimenti, 2006). However, there is speculation that dermatology providers are not consistent
in their analysis and detection of depression in patients with skin disease (Sampogna, Picardi,
Melchi, Pasquini, & Abeni, 2003). In a study comparing dermatology providers’ opinions of the
prevalence of psychological co-morbidity in their patient population compared to the actual data
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collected from the patient, Sampogna et al. (2003) found that dermatologists believe depression
and decreased QOL are less frequent in patients with skin disorders than is actual.
To address possible inconsistencies in screening for and treating depression in patients
with plaque psoriasis and atopic dermatitis, an evaluation of the current state of mental health
assessment by dermatology providers must first be completed. Using a screening questionnaire,
this project evaluates the provider use, comfort, and proficiency in screening for and discussion
of depression in a dermatology practice with clinics in Louisville, Lebanon, Leitchfield, and
Shelbyville Kentucky as well as New Albany Indiana. The result of this assessment will provide
information concerning the ability of the clinic providers to screen for and intervene in
depression in patients with plaque psoriasis and atopic dermatitis. It will also determine if
provider education is needed as a means to improve patient care.
Background
According to the American Psychological Association (APA), depression is defined as,
“More than just sadness. People with depression may experience a lack of interest and pleasure
in daily activities, significant weight loss or gain, insomnia or excessive sleeping, lack of energy,
inability to concentrate, feelings of worthlessness or excessive guilt and recurrent thoughts of
death or suicide.” (APA, 2015). The World Health Organization (WHO) states depression
accounts for 4.3% of the global burden of disease and is the largest cause of disability worldwide
(WHO, 2013). According to the CDC, the economic impact of depression in the U.S., which
includes workplace costs, direct costs, and suicide, was $210.5 billion in 2010 (CDC, 2016). In
addition, depression is also known to coincide with serious medical illnesses such as cancer,
diabetes and skin disease (The National Institute of Mental Health (NIMH), 2016).
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It is estimated that between 35%-50% of patients with depression receive no treatment
due to poor screening practices and insufficient referral to mental health providers (WHO, 2013).
In January 2016, the United States Preventive Services Task Force (USPSTF) released an official
recommendation stating the need for all adult patients to be screened for depression in the
primary care setting (USPSTF, 2016). The document states that screening should be performed
in order to “ensure accurate diagnosis, effective treatment, and appropriate follow up” (USPSTF,
2016, p. 380). Therefore, it may be important that patients suffering from skin disease are
assessed for depression in the dermatology setting; especially since a dermatology provider is the
first and perhaps only medical professional many of these patients see on a regular basis (Peters,
2016).
Psoriasis and atopic dermatitis are considered psychodermatological disorders because
they are triggered and exacerbated by psychological stress (Koo & Lee, 2003; Jefferany, 2011;
Peters, 2016). The relationship between skin disease and depression can be characterized as
bidirectional due to the fact that depression activates a lesion flare and the presence of skin
lesions exacerbates feelings of depression (Pietrzak et al, 2017). Both psoriasis and atopic
dermatitis are caused by the immune-mediated release of inflammatory cytokines in the
epidermal layer of the skin initiating the development of skin lesions (NPF, 2015; NEA, 2015;
Tohid, Aleem, & Jackson, 2016; Peters, 2016). Psoriatic lesions are frequently located on the
elbows, knees, scalp, or lower back and are characterized by raised, red patches covered with
silver/white “scales” or dead skin cells (NPF, 2015). Atopic dermatitis lesions are red, dry
patches most often located on the arms, legs, and cheeks (NEA, 2015). Patients who suffer from
these skin diseases experience impaired self –image, social embarrassment, and severe itching,
also known as pruritus, which can lead to cracking, bleeding, pain, and insomnia (Kemmerling,
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2013; NEA, 2015; NPF, 2015). A vicious cycle is created when depression and stress perpetuate
skin disease, leading to itching, insomnia, and social isolation, which ultimately triggers
increased severity of skin lesions through continued exacerbation of stress pathways (Gupta &
Gupta, 2003; Jefferany, 2011; Gordon-Elliot & Muskin, 2013; Peters, 2016; Pietrzak et al, 2017).
Early detection and diagnosis of depression is not only important to proper management
of the skin disease (Bashir, Dar, & Rao, 2010; Jefferany, 2011; Peters, 2016), but it is also
important to the management of other possible comorbidities (Egeberg, Khalid, Hilmar Gislason,
Mallbris, Skov, & Riis Hansen, 2016). In a case-control study, Egeberg et al (2016) found that
untreated depression in patients with psoriasis can be associated with an increased risk of
myocardial infarction, stroke, and cardiovascular death. Therefore, proper detection of
depression can be important to prompt discussion or early referral to a provider that can treat
depression, leading to timely treatment of psychological co-morbidities (Richards, Fortune,
Weidmann, Sweeney, & Griffiths, 2004). Effective treatment by a trained primary care or
mental health provider paired with successful care by a certified dermatology physician or
advanced practice provider (APP) can eventually lead to a more holistic, successful, and costeffective treatment of skin disease and may therefore lead to decreased cardiovascular risk
(Egeberg et al, 2016; Richards et al, 2004; NIMH, 2016; Peters, 2016). In a randomized control
trial, Schmitt et al (2014) discovered that patients suffering from psoriasis and depression
benefitted from interdisciplinary care when compared to those that received dermatological care
alone, as indicated by increased QOL scores.
Nevertheless, depression in patients with skin disease goes unrecognized due to improper
screening measures (Picardi et al, 2004; Peters, 2016), inaccurate perception of psychiatric
morbidity (Sampogna et al, 2003), and the dermatology provider’s assumption that the severity
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of disease indicates the level of depression risk (Gupta & Gupta, 2003; Cohen, Martires, & Ho,
2015). Furthermore, although the psychocutaneous aspects of psoriasis and atopic dermatitis are
becoming more accepted in the academic world, many dermatology providers still hold the
misconception that successful treatment of the skin disease indicates successful treatment of the
psychological co-morbidity (Richards et al, 2004; Kemmerling, 2013). For example, Richards et
al (2004) discovered that when dermatology providers identified patients as being depressed it
was only addressed during the visit in 1/3 of the cases and a referral was made to a mental health
service in only one of the cases examined. In this study, the providers suggested the belief that if
they controlled the patient’s psoriasis properly the depression symptoms would also disappear
(Richards et al, 2004). Other barriers to appropriate screening practices include time restraints
during the clinic visit, fear of stigmatizing patients, and difficulties with patient-provider
communication of depression (Richards et al, 2004).
For the past twenty years, research to address this problem has focused on methods for
quick and accurate detection of depression in the patient with skin disease through the use of
screening tools. Tools such as the General Health Questionnaire (GHQ-12), Primary Care
Screener for Affective Disorders (PC-SAD), Patient Health Questionnaire (PHQ),
Psychosomatic Scale for Atopic Dermatitis; PSS-AD, ShortForm36, and Skindex, have all been
used to help assess level of depression in patients with skin disease. However, consensus on a
gold standard screening tool has not been accomplished so clinical practice guidelines for the
screening of depression in patients with skin disease have not been created. In addition, there is
concern that if a gold standard screening tool were selected, many dermatology providers may
not use such a tool because they may lack the proper training to discuss depression with their
patients (Richards et al., 2004; Johnson et al., 2014; Kemmerling, 2013). Therefore, an
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evaluation of the knowledge, attitudes, perceptions, skills, and self-efficacy of depression and
QOL will be important to understand dermatology providers’ perceptions on whether they are
properly equipped to screen for and engage in discussions about depression with their patients.
The results of this evaluation are expected to determine if provider education focused on proper
screening for and discussion of depression is warranted in the treatment of patients with plaque
psoriasis and atopic dermatitis in the dermatology setting.
Purpose
The purpose of this project is to evaluate the knowledge, attitudes, perceptions, skills, and
self-efficacy in assessing for depression among patients by dermatology providers in a
dermatology practice with clinics in Louisville, Lebanon, Leitchfield, and Shelbyville, Kentucky
as well as New Albany, Indiana in order to determine the need for continuing education
programs.
Proper screening of depression by dermatology providers is important to achieving
holistic care of patients suffering from plaque psoriasis and atopic dermatitis. By evaluating the
knowledge, attitudes, perceptions, skills, and self-efficacy of depression screening in
dermatology providers, the need for provider education can be determined. Specifically this
project has two objectives. The first objective is to determine if there is relationship between
provider demographic data and practice of screening for depression in patients with chronic skin
disease. Demographic measures assessed in the survey include age, gender, ethnicity, job title,
and work tenure. Understanding the association between demographic data and screening
practices may open the door to understanding what age, gender, ethnicity, discipline, or level of
experience is comfortable with screening for depression while also determining those levels that
may benefit from education in the future.
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The second objective of this project is to determine how provider behavioral intention,
provider attitude, subjective norms, perceived behavioral control, use of SBIRT (Screening,
Brief Intervention, and Referral to Treatment), provider confidence, and performance barriers
can affect the practice of screening for depression in patients with chronic skin disease by
dermatology providers. It is the hope that understanding these variables’ effects on screening for
depression in patients with skin disease can help guide the development of educational courses
on screening for depression.
Methods
This is a single practice, multi site, quantitative correlational design study to assess
provider use, comfort, and proficiency of screening for and discussion of depression in patients
suffering from plaque psoriasis and atopic dermatitis. Data was collected through the use of a
questionnaire assessing knowledge, attitudes, perceptions, skills, and self-efficacy of screening
for depression. The questionnaire was dispensed in January 2018 to twenty-three providers
currently practicing at a dermatology clinic with locations in Louisville, Lebanon, Leitchfield,
and Shelbyville, Kentucky as well as New Albany, Indiana. Questionnaires were reviewed and
data analysis was completed using the SPSS statistical software in February of 2018.
Setting
The study site is comprised of seven clinic locations with three in Louisville, Kentucky,
one in Lebanon, Kentucky, one in Leitchfield, Kentucky, one in Shelbyville, Kentucky, and one
location in New Albany, Indiana. The providers include sixteen physicians, three nurse
practitioners, and four physicians assistants. Services provided by the practice include general
dermatology, cosmetic dermatology, and Mohs micrographic surgery. The mission of the
practice “encompasses three arenas of excellence and advancement in the provision of
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dermatologic care in Louisville, Kentucky and it’s surrounding regions: Service to patients,
Education, and Leadership” (AID, 2017).
Sample
The convenience sample participants for this evaluation are current providers of services
at the practice. There are now 23 providers in the practice with ages ranging from approximately
30-65 years of age. Of the current providers there are five male and eighteen female providers.
Inclusion criteria for participation in this study included; providers who give care at any of the
seven locations in Kentucky and Indiana, board certified physicians, advanced practice nurse
practitioners (APRNs), and certified physician assistants (PA-C). Exclusion criteria blocking
participation in this study included; medical students, nurse practitioner students, research
physicians, dermopathologists, registered nurses, and medical assistants.
Questionnaire
A questionnaire assessing the knowledge, attitudes, perceptions, skills, and self efficacy
of depression screening was developed for data collection (Figure 1). This questionnaire was
adapted from an already existing document used in a previous study to assess primary care
providers’ knowledge, attitudes, perceptions, skills, and self-efficacy of discussing smoking
cessation with patients in the clinical setting (Okoli, Otachi, Kaewbua, Woods, and Robertson,
2017). The questionnaire was developed based on Icek Ajzen’s (2011) work on how to construct
a questionnaire based on the theory of planned behavior. With Okoli et al.’s approval, their
questionnaire was used as a template for the construction of the questionnaire for this study.
Changes were made in order to fit the study topic of screening for depression in patients with
chronic skin disease. The paper survey consists of a total of 48 questions; 45 assessment
questions and 3 survey evaluation questions. The questionnaire obtains knowledge through
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inquiries assessing participant demographic information, the theory of planned behavior, use of
screening, brief intervention, and referral to treatment (SBIRT), provider confidence, and
opinions about possible barriers to intervention.
Demographics. Demographic variables are assessed through five questions that include
gender, ethnicity, age, job title and work tenure. These questions will be used to determine if
there is a correlation between demographic data and the practice of screening for depression in
patients with skin disease.
Theory of Planned Behavior. The theory of planned behavior has been used to predict
and justify behaviors in the healthcare field. According to this theory developed by Icek Ajzen,
there is strong correlation between one’s beliefs and one’s decision to participate in a certain
behavior (Ajzen, 1991; 2011). This questionnaire contains fifteen questions assessing the four
components of the theory of planned behavior; behavioral intention, attitude, subjective norms,
and perceived behavioral control. Questions assessing behavioral intention are to determine the
provider’s readiness to perform the screening process. Those assessing attitude are observing the
participant’s positive or negative evaluation of screening for depression in patients with skin
disease. Subjective norms are obtained through questions assessing the providers perception of
significant others and/or colleagues approval or disapproval of the screening process. Lastly,
perceived behavioral control is assessed through questions assessing the provider’s perception on
the ease or difficulty of screening for depression in patients with skin disease. The answers to
these questions will be used to determine if the provider’s beliefs about screening for depression
affect the decision to practice screening in the clinic setting.
SBIRT. Screening, brief intervention, and referral to treatment (SBIRT) was first
developed as a public health model to provide effective screening, secondary prevention, early
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recognition and treatment for patients suffering from unhealthy alcohol use in the primary health
care setting (SAMHSA, 2011). A 2011 report released by the Substance Abuse and Mental
Health Services Administration (SAMHSA) stated that SBIRT could be successfully
implemented in the diagnosis and treatment of depression. In addition, a study by Dwinnells
(2015) found that SBIRT is effective in the assessment of patients at risk for depression in the
primary care setting. The questions focused on SBIRT assess the providers use of this evidence
based method through three questions asking about how often they screen for depression,
perform behavioral interventions, and refer patients to behavioral health.
This portion of the questionnaire also evaluates provider confidence in their skills to
perform SBIRT through four questions evaluating confidence in screening for and discussing
depression in the dermatology setting. Assessing use of this method by the dermatology
providers in this study will help in the prioritization of future provider education on proper
methods of screening for depression in the dermatology setting. SBIRT replaces Okoli et al.’s
(2017) use of the 5 A’s (ask, advise, assess, assist arrange) of smoking cessation. The 5 A’s
assessment tool is specific to smoking cessation, therefore the tool had to be replaced by SBIRT
in order to make the assessment relevant to depression screening practices.
Barriers to Intervention. Delay of depression intervention and treatment in the
dermatology setting can be due to patient specific, provider specific and organizational specific
barriers to performing depression screening. The questionnaire used in this study includes 21
questions evaluating possible barriers to screening and discussion of depression in patients with
chronic skin disease. Possible barriers include provider views on realm of practice, confidence,
knowledge of the referral process, patient ideas about discussion of depression in the
dermatology setting, time constraints, protocol availability, training, and resource availability.
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Data Collection
Approvals from the University of Kentucky Institutional Review Board (IRB), practice
Chief Administrative Officer and practice physician in charge of research activities were
obtained prior to the collection of data. This study is based on results from a 48-question survey
dispensed in January of 2018. All current providers were contacted during a practice wide
provider staff meeting on January 17th, 2018. All providers were given a copy of the cover letter
and questionnaire. A formal informed consent process was waived per IRB approval and
replaced with the inclusion of a cover letter describing the study activities. Participants who have
read the cover letter and completed the questionnaire are granting consent that data may be used
in the analysis of the research question. Participants were given two weeks to complete and
return the survey, with a final due date of January 31, 2018. Questionnaires were collected and
reviewed in February of 2018. Variables reviewed included demographic data (age, ethnicity,
gender, job title, and work tenure) and outcomes variables (behavioral intention, attitude,
subjective norms, perceived behavioral control, SBIRT in practice, confidence, and barriers
(Table 1).
Data Analysis
Data analysis was completed using the IBM SPSS statistical software version 22. The
demographic characteristics of the sample were described using frequencies and percentages for
nominal and ordinal variables (gender, ethnicity, job title) while means and standard deviations
were used for interval/ratio variables (age and work tenure). Data to describe results for
knowledge, attitudes, perceptions, skills, self-efficacy, and barriers were scored on a Likert scale
to create interval/ratio levels of measurement. Analysis of this data was completed using means
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and standard deviations with t-test and chi-square tests to determine variance. Level of
significance will be determined using p < 0.05.
This study is assessing how provider demographic characteristics and personal beliefs
affect screening for depression in practice. Therefore, outcome variables were analyzed based on
the providers’ answer to Section C: SBIRT in practice/role, question 1 of the questionnaire,
which assesses for the frequency of screening for depression. The question asks, “In your
practice/role, how often do you screen for depression in patients with chronic skin disease during
clinic visits?” The possible answers to this question are never, seldom, occasionally, and very
often. In order to properly examine the effect of demographic and outcome variables on
screening practice, the SBIRT data was recoded from four possible answers to two answers to
decrease the number of values for improved analysis. Those who answered seldom or never were
categorized as not screening for depression (0 = no) and those who answered occasionally or
very often were categorized as participating in screening practices (1 = yes). Please refer to
Table 1 for a full description of study measures and statistical analysis techniques.
Lastly, provider feelings toward the need for future educational programs on the proper
practice of screening for depression in patients with skin disease was determined through the
assessment of questions 8, 17, and 18 in Section D: Barriers to intervening with patients who
suffer from depression. Section D, question 8 asks, “ Many clinicians are willing, but are not
properly equipped to engage in advice and/or intervention when it comes to depression.” In
addition, question 19 states, “ There is a lack of training for clinicians to engage in discussion
about depression in patients with skin disease” Finally, Section D, questions 18 states “There is a
need for written protocols to document clinician responsibilities for providing discussion about
depression in patients with skin disease.” The possible answers to these questions are Never,
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Seldom, Occasionally, and Very Often. In order to properly examine the answers to these
questions, the data was recoded for improved analysis from four possible answers to two
answers. Those who answered seldom or never were categorized as answering no (0 = no) and
those who answered occasionally or very often were categorized as answering yes (1 = yes).
Results
Sample Characteristics
At the time of data collection there were 23 providers practicing at the seven clinic
locations. Three of the providers were excluded from the sample since they practice as certified
dermopathologists and do not see patients. Another three providers chose not to participate in the
study. At the time of collection, a total of 17 providers submitted a completed questionnaire for
data analysis. Of the providers that participated, 5 were male (29.4%) and 12 were female
(70.6%), with the majority identifying as White, non-Hispanic (88.2%). Most of the participants
were board certified physicians (64.7%) with the remainder being advanced practice providers
(APPs), such as advanced practices nurses or physician assistants (35.2%). The mean age of
participants is 44.6 years old with a mean practice experience of 14.2 years. Please refer to Table
2 for a full breakdown of demographic characteristics.
SBIRT in Practice
After recoding the data, it was found that of the 17 providers that participated in the study
12 (70.6%) practice screening for depression in patients with skin disease while 5 (29.4%)
providers do not practice screening for depression. Of the 12 providers that screen, only 3(25%)
perform behavioral interventions. In order to assess for variance between performing behavioral
interventions and not performing behavioral interventions in those providers who screen, a chisquare test of independence was performed. It was found that this association was not
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statistically significant with a p value of .52 (Fisher’s exact test). In addition, 8(66.7%) of the
screening group of providers claim they will refer patients to mental health providers if they
screen positive for depression. A chi-square test of independence showed no statistical difference
between referral and non-referral in those providers who admit to screening for depression;
p=.59, Fisher’s exact test. Lastly, it was discovered that only 2 (11.8%) of the providers that
practice screening for depression implement both behavioral interventions and referral to mental
health, completing the SBIRT process.
Demographic effect on screening practices
It was hypothesized that provider demographic characteristics may have an affect on their
practice of screening for depression in the dermatology clinic. In order to assess this hypothesis,
data was analyzed through t-test and chi-square test calculations. Two separate independent
samples t-tests were conducted to compare provider age and years of experience to screening and
non-screening conditions. For age there was no significant difference in the scores for screening
(M=43.4, SD=10.7) and non-screening (M=48.0, SD=7.3) conditions; p = .38. In years of
practice there was also no significant difference seen between screening (M= 13.1, SD=10.6) and
non-screening (M=16.8, SD=8.9) conditions; p=.51.
Furthermore, three separate Chi-square tests of independence were performed to
determine relation between gender, race, and type of providers in screening practices. A higher
percentage of women (75%) screened for depression than men (60%), however this value was
not statistically significant; p=.60, Fisher’s exact test. In addition, 80% of white providers and
0% of Asian providers screen for depression, yet the relation between these variables was not
significant; p=.07, Fisher’s exact test. Lastly, 63.6% of physicians, 66.7% of APRNs, and 100%
of PAs regularly screen for depression. The chi-square test of independence confirmed that the
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relation between provider type and screening practice was also not significant; p=.76, Fisher’s
exact test. Overall, there was no significant data to explain an association between provider
demographics and screening practices. Please refer to Table 3 for all data obtained from the
statistical analysis.
Intentions, Attitudes, Social Norms, and Perceived Behavioral Control
In order to assess if provider beliefs do in fact determine practice of screening for
depression in the dermatology clinic, independent sample t-tests were used to evaluate provider
intention, attitudes, social norms and behavioral control to screening and non-screening practices
(Table 4). There was no statistical significance in attitudes of the screening group (M=5.2,
SD=1.3) and non-screening group (M=3.2, SD=2.3); p=.30. Also, there was no significant
difference between perceived behavioral control of providers who practice screening (M=4.7,
SD=0.75) and those who do not screen (M=4.2, SD=0.89); p=.23. However, statistical
significance was seen in the evaluation of provider intention and perception of importance of
screening of depression through subjective norms. The 12 providers in the screening group
(M=5.5, SD=1.3) and the 5 providers in the non-screening group (M=3.2, SD=2.3) showed
significant difference in intention scores with a p value of .02. In addition, those providers who
practice screening for depression (M=3.9, SD=1.1) versus those who do not screen (M=2.4,
SD=1.8) had significant difference in subjective norms scores; p=.04. These results suggest that
intention and subjective norms scores are higher for those providers who screen for depression in
their current practice.
Confidence
It was hypothesized that provider confidence in discussing and treating depression could
have an effect on screening practices. Those who screen for depression did have a higher mean
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confidence score (6.8) than those providers who do not screen (4.1). An independent samples ttest was conducted to compare confidence in screening for depression and non-screening for
depression conditions. There was no significant difference in scores for screening (M=6.8,
SD=1.1) and non-screening (M=4.1, SD=4.1) conditions; p=.21. These results suggest that
confidence in screening for depression of the dermatology provider may not have an effect on
actual screening practice. Please refer to Table 4 for data.
In addition, the association between mean confidence score and performance of the
remaining SBIRT steps, behavioral interventions and referral to a mental health provider, were
assessed. An independent sample t-test was performed to assess confidence in performing
behavioral interventions (M=8.0, SD=.66) and not performing behavioral interventions (M=5.5,
SD=2.7). This analysis did not show significance between these variables; p=.14. Lastly, an
independent samples t-test was done to compare confidence in providers who refer patients to
mental health providers and those who do not refer to mental health providers. There was no
significant difference in confidence scores for those who refer (M=6.7, SD=1.9) and those who
do not refer (M=4.2, SD=3.2); p=.17. Although mean confidence scores are higher in providers
who practice behavioral interventions and those who refer patients to mental health providers,
this data does not show a significant association between these variables.
Barriers to intervention
Lastly, it is thought that the existence of specific barriers in practice may determine if
depression screening is performed by dermatology providers. In order to analyze this hypothesis
separate independent sample t-tests were completed to compare provider barriers, patient barriers
and system/organization barriers in screening and non-screening conditions (Table 4). There was
no significant difference in data for provider barriers (p=.38), patient barriers (p=.17), and
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system/organization barriers (p=.96). Please refer to table 4 for patient, provider, and
system/organization barrier means and standard deviations. These results indicate that possible
barriers to practice may not directly have an effect on the provider’s habit of screening for
depression.
In order to assess for provider thoughts on need for education in screening for and
discussion of depression in patients with skin disease Section D: Barriers to intervening with
patients who suffer from depression questions 8, 17, and 18 were evaluated. Of the participants,
11(64.7%) indicated they feel as if clinicians are willing but are not properly equipped to engage
in advice and or intervention when it comes to depression. In addition, 13 (76.4%) of participants
indicated the need for written protocols for screening for and discussion of depression in patients
with skin disease. Lastly, all 17 providers indicated that they believe there is a lack of training
for dermatology clinicians to properly engage in discussion about depression with the patients
suffering from skin disease. These results indicate current providers feel that more provider
education may be warranted in this subject matter.
Evaluation of the Survey
Participants were asked to evaluate the questionnaire based on length of the survey,
understanding of the questions, and interest in participating in this topic of research in the future.
Many of the participants felt the questionnaire length was too long (52.9%) while the remaining
felt it was the right amount of questions (47.1%). The majority of the providers (82.4%) did not
have a problem understanding the questions. When it came to future participation in research on
screening for depression in patients with skin disease, 47.1% said no to future involvement while
52.9% said yes they would be interested in contributing if needed. In addition, 3 of the 17
participants wrote comments about their thoughts on the questionnaire. These three participants
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mentioned confusion of switching from negative to positive scales versus positive to negative
scales in some of the questions.
Discussion
This study aims to better understand how demographic characteristics, provider beliefs,
confidence, and possible barriers to practice affect provider habit of screening for depression in
the dermatology setting. Current literature suggests that screening for depression in patients with
chronic skin disease can lead to more holistic care of the patient. Unfortunately, the literature
also shows that dermatology providers are not consistently screening for depression in their
current practice. This study is the first to assess provider knowledge, attitudes, perceptions,
skills, and self-efficacy as a way to understand how we can improve rates of screening in the
future. Overall, the study results and analysis do not demonstrate strong data to associate
provider demographic characteristics, confidence, and practice barriers in the decision to screen
for depression. However, there was statistical significance in the association between provider
behavioral intention and subjective norms in screening practice. In other words, the data shows
that providers who screen feel they have a professional commitment to perform a depression
assessment. In addition, the data illustrates that providers who screen feel a level of social
pressure to engage in screening for depression in patients with skin disease.
SBIRT in practice
SBIRT was first developed as a tool to increase the rates of early screening, brief
intervention and referral to treatment of patients suffering from alcohol dependence and abuse in
the primary care setting (SAMHSA, 2011). In 2011, SAMHSA released a statement explaining
that this method could also be implemented in the assessment of patients at risk for depression in
the primary care setting. In this study, 70.6% of the participants admit they do screen for
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depression in patients with chronic skin disease in their current practice. While 66.7% of the
providers who screen state they will refer patients positive for depression to a provider who can
properly treat depression, only 25% say they perform behavioral interventions during the clinic
visit. Although it has been found that SBIRT has been successfully utilized to provide more
holistic care in patients at risk for depression (Dwinnells, 2015), the participants in this study
who actively screen for depression in patients with skin disease are not using this evidence based
practice method to its full potential. In order to insure that all three aspects of the SBIRT model
are performed in patients with depression in the dermatology setting an educational program
should be developed and implemented.
In addition, it was seen that the mean confidence score of those who screen for
depression was higher than the mean confidence score of those who do not screen. Confidence
was evaluated through questions concerning the assessment for depression, discussing
depression with patients, recommending therapy for depression, and explaining the effects of
depression on skin health. Although the confidence data obtained from this study is not
statistically significant, it may help point to areas of future research on this topic. It is possible
that education programs focused on screening for and discussion of depression in patients with
skin disease could increase provider confidence in the topic and therefore increase the rate of
depression screening in their practice.
Demographic affect on screening practices
It was hypothesized that the provider’s demographic characteristics may have an effect
on depression screening practices in the clinical setting and therefore determine the focus of
provider education. When is comes to age, sex, ethnicity/race, discipline, and years of practice
compared to screening practice the data obtained in this study was not statistically significant.
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This indicates that there is no association between provider demographics and decision to screen
in practice. However, it was seen that while 63.6% of physicians screen for depression in patients
with skin disease as high as 83.3% of APPs (APRNs and PAs) screen for depression in their
current practice. It is interesting that such a high percentage of APP’s already screen for
depression in the dermatology setting. Although this data is not significant, it may help point to
topics of future research. Perhaps understanding the differences between MD versus APRN/PA
training, goals of care, or methods of practice in the dermatology setting could assist in the
development of future educational programs on screening for depression in patients with skin
disease.
Intentions, Attitudes, Social Norms, and Perceived Behavioral Control
The theory of planned behavior is used to predict and justify behaviors in the healthcare
field based on the idea that there is correlation between one’s beliefs and decision to participate
in a certain behavior (Ajzen, 1991; 2001). There are four components of this theory; behavioral
intention, attitude, subjective norms, and perceived behavioral control (Ajzen, 1991; 2001).
According to Ajzen (1991), high intention scores usually lead to the performance of the
behavior. However, there are circumstantial limitations or barriers that stop the evolution from
high intention to implementation of the specific behavior (Ajzen, 1991; 2001). In the case of
provider practice of screening for depression in patients with skin disease, perhaps lack of
knowledge, skills, confidence, and self-efficacy acts as a circumstantial limitation to the
performance of the screening behavior. Therefore, provider education on proper SBIRT practices
and initiating discussion about depression could serve as a method to reduce the barriers to
performing screening for depression in patients with skin disease. Please refer to Figure 1 for a
visual description of the Theory of Planned Behavior.
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In this study, there was significant association between behavioral intention and
subjective norms scores in a provider’s decision whether or not to screen for depression in
patients with skin disease. The providers’ mean behavioral intention score, or readiness to
perform depression screening in the dermatology setting, was significantly higher in participants
who currently screen for depression. In addition, the mean subjective norms score, or the
provider’s perception of their significant others/colleagues approval of the screening process,
was significantly higher in the screening group than the non-screening group. These figures
indicate that those who have a strong professional commitment and feel social pressure from
significant others and colleagues are more likely to screen for depression. Attitude and perceived
behavioral control scores were also higher in the providers who screen for depression, however
this data was not significant.
The data obtained from this study is in accordance with the ideas of Ajzen’s Theory of
Planned Behavior. In the theory, high levels of attitude, subjective norms and perceived
behavioral control cause high intention. Subsequently, high intention scores lead to performance
of the behavior. This data could be used to demonstrate the importance of using the Theory of
Planned Behavior to guide the development of future educational programs on how to screen for
and discuss depression in the dermatology setting. Educational programs can be used as a
method to decrease circumstantial barriers through an increase in provider knowledge, skills,
confidence, and self-efficacy.
Barriers to intervention
Barriers to screening and intervention in patients with skin disease who suffer from
depression can be caused by provider, patient and system/organization specific causes. Some of
these barriers include provider comfort, visit time constraints, fear of stigmatizing patients,
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available resources, and difficulties engaging in patient/provider education (Richards et al,
2004). In this study, mean scores for provider, patient and system/organization barriers were
nearly identical between groups. In addition, there was no significant data to indicate that
possible barriers have an effect on a provider’s practice of screening for depression in patients
with skin disease.
However, this section of the questionnaire did provide insight to provider thoughts about
the need for educational programs and practice guidelines when it comes to screening for
depression in the clinical setting. The majority of the study participants indicated the belief that
clinicians are not properly equipped to engage in discussion about depression. Furthermore,
94.1% of participants specified the need for written protocols and/or clinical practice guidelines
when it comes to screening for and discussion of depression in patients with skin disease. And
most importantly, all 17 providers indicated the lack of training in the screening for and
discussion of depression in the dermatology setting. This data illustrates that providers who
participated in this study may be open to not only receiving education on screening for and
discussion of depression in patients with skin disease but also to using protocols to guide
screening, referral and treatment of these patients.
Limitations
Several limitations were identified in the design of this study. The sample size was small
(n=17) making it difficult to ensure a representative distribution of the findings. In addition,
although the data was collected from multiple sites, it was representative of a single clinical
practice, further limiting the generalization of the results. Also, a possible limitation is
imbalanced interpretation of inquiries in the questionnaire by the research participants. For
example, the majority of questions were asked on a Likert scale with the lower score indicating
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the negative answer while the higher score indicated the positive. In section B of the
questionnaire there are two questions reversing the scale, which may have caused some
confusion and therefore inaccurate answers. The length of the questionnaire (48 questions) can
also serve as a limitation due to the possibility that the participants hurried to answer all the
questions in order to return to their normal duties. Lastly, data collected via questionnaire is selfreported data, which is infrequently independently verified and can contain sources of responder
bias.
Recommendations for future studies
Recommendations for future studies include continued assessment of provider
knowledge, attitudes, perceptions, skills, and self-efficacy of screening for depression in the
dermatology setting using a larger sample size in order to better capture the impact of these
variables on actual screening practice. Once stronger data is collected, educational programs on
screening for and discussion of depression in patients with skin disease can be created with the
goal of improving provider confidence in caring for these patients. In addition, this data could
aid in the development of clinical practice guidelines on screening, discussion, and referral of
patients with chronic skin disease who also suffer from depression. Finally, pre-test/post-test
studies should be performed after proper education and or guideline implementation. It has
already been discovered that early detection of depression as a comorbidity and prompt
interdisciplinary care by the dermatology and mental health provider signifies improved QOL in
patients with skin disease. Future research should be focused on how dermatology provider
screening and referral practice can be expanded in order to increase the number of patients who
are properly treated for their concurrent skin disease and depression.
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Conclusion
This study is the first to assess provider knowledge, attitudes, perceptions, skills, and
self-efficacy as a way to understand how we can improve rates of screening for depression in the
future. Data obtained from this analysis was used to determine what additional provider
education is needed in order to increase the incidence of screening for and discussion of
depression in the dermatology setting. The majority of participants (70.6%) do actively screen
for depression in their daily practice. However, the data suggests that many of the providers are
not utilizing all aspects of the SBIRT model in the assessment of patients with possible
depression. Unfortunately, no statistical significance was found to associate provider
demographic characteristics, confidence, and practice barriers in the decision to screen for
depression. Yet, there was statistical significance in the association between provider behavioral
intention and subjective norms in screening practice. In addition, all 17 providers indicated the
need for education on screening for depression in the dermatology setting. Therefore, the data
obtained from this study concerning SBIRT, the theory of planned behavior, and provider
thoughts on the lack of instructional programs demonstrates the need for continuing education on
depression screening for dermatology providers. In the future, additional research needs to be
completed in order to better understand what topics should be included in educational programs.
The primary goal of this research is to increase the number of dermatology patients who benefit
from a more holistic method of care.
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Table 1. Table of Study Measures
Table of Study Measures
Measures
Demographics
Gender
Ethnicity

Job title
Age
Work tenure
Outcome
Intention

Attitude

Subjective Norms

Perceived Behavioral Control

SBIRT in Practice

Confidence

Barriers

Description

Level of Measurement

Analysis

Data Source

Male vs. Female
White, Black, Hispanic,
Indian, Native American,
Middle Eastern, Mixed Race,
Asian, Other
MD, APRN, or PA
Age in years
Length of time at job in years

Nominal
Nominal

Frequencies, Chi-square
Frequencies, Chi-square

Questionnaire
Questionnaire

Nominal
Interval/ratio
Interval/ratio

Frequencies, Chi-square
Means (SD), t-tests
Means (SD), t-tests

Questionnaire
Questionnaire
Questionnaire

Provider intent to perform
depression screening in
patients with skin disease is
assed by assessing if the
expect to screen, want to
screen and intent to screen
Providers are asked on a scale
of 1 to 7 if screening for
depression is 1) harmfulbeneficial 2) good-bad 3)
Pleasant for you-Unpleasant
for you 4) worthless-useful to
their practice.
Providers are asked if 1)
people important to them 2) it
is expected of them 3) under
social pressure 4) expected
from peers to perform
screening on patients with
skin disease.
Providers are asked perceived
behavioral control of the
performance of depression
screening in patients with
skin disease based on
1) Level of confidence in
performing the task, 2)
difficulty of providing
screening, 3) believe decision
beyond their control, and 4)
believe the decision to
provide screening is in their
control.
Providers are asked how often
(never, seldom, often, always)
they perform the following
tasks in their practice role 1)
Screening for depression 2)
Behavioral Intervention for
those with depression 3)
Referral to Behavioral Health
Treatment
Providers asked on scale of 110 rate confidence of current
skills to 1) determine degree
of depression in patients 2)
Discuss depression with
patients 3) Recommend
therapy for depression 4)
Explain effects of depression
on skin health

Interval/Ratio

Mean (SD), t-tests

Questionnaire

Interval/Ratio

Mean (SD), t-tests

Questionnaire

Interval/Ratio

Mean (SD), t-tests

Questionnaire

Interval/Ratio

Mean (SD), t-tests

Questionnaire

Interval/Ratio

Mean (SD)

Questionnaire

Interval/Ratio

Mean (SD), t-tests

Questionnaire

Provider asked if they
completely disagree,
somewhat disagree,
somewhat agree, or
completely agree with listed
provider specific, patient
specific and system specific
barriers to depression
screening in the dermatology
setting.

Interval/Ratio

Mean (SD), t-tests

Questionnaire
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Table 2. Demographic Characteristics
Demographic Characteristics
Characteristic
Age, years Mean (SD)
Sex
Male
Female
Ethnicity/Race
White, non-Hispanic
Black, non-Hispanic
Hispanic
Asian, Pacific Islander
Discipline
Physician (MD)
Physician (DO)
Advanced Practice Nurse (APRN/CNS)
Physician Assistant (PA)
Years of practice, mean (SD)
Notes: Standard Deviation (SD)
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n (%)
44.6 (9.8)
5 (29.4%)
12 (70.6%)
15 (88.2%)
0 (0%)
0 (0%)
2 (11.8%)
11 (64.7%)
0 (0%)
3 (17.6%)
3 (17.6%)
14.2 (10.04)

Table 3. Associations among demographic characteristics and screening for depression
Demographic
Yes (n=12)
No (n=5)
p
Characteristic
Mean (SD) or n (%)
Mean (SD) or n (%)
Age
43.3 (10.7)
48.0 (7.3)
.38
Gender
Male
3 (60.0%)
2 (40.0%)
.60
Female
9 (75.0%)
3 (25.0%)
Race
White
12 (80%)
3 (20%)
.07
Asian
0 (0.0%)
2 (100%)
Type of provider
MD
7 (63.6%)
4 (36.4%)
APRN
2(66.7%)
1 (33.3%)
.76
PA
3 (100%)
0 (0.0%)
Years of experience
13.1 (10.6)
16.8 (8.9)
.51
Notes: Standard Deviation (SD), Physician (MD), Advanced Practice Nurse (APRN),
Physician Assistant (PA)

NEED FOR PROVIDER EDUCATION ON SCREENING FOR DEPRESSION

28

Table 4. Association among provider knowledge, attitudes, perceptions, skills, and self-efficacy
and screening for depression
Yes (n=12)
No (n=5)
p

Intention
Attitudes
Subjective Norms
Perceived Behavioral
Control
Confidence
Provider Barriers
Patient Barriers
System/Organization
Barriers

Mean (SD)
5.5 (1.3)
5.2 (1.1)
3.9 (1.1)

Mean (SD)
3.2 (2.3)
4.5 (1.6)
2.4 (1.8)

.02
.30
.04

4.7 (0.75)
6.8 (1.1)
2.2 (.44)
2.4 (.40)

4.2 (0.89)
4.1 (4.1)
2.4 (.52)
3.1 (.82)

.23
.21
.38
.17

3.3 (.33)

3.3 (.56)

.96
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Figure 1. The Theory of Planned Behavior
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